Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.72 USD | +1.27% | -0.79% | -1.93% |
Mar. 20 | Myriad Genetics Gets US Patent for SneakPeek Snap Device | MT |
Feb. 27 | Transcript : Myriad Genetics, Inc., Q4 2023 Earnings Call, Feb 27, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.93% | 1.67B | |
+0.80% | 12.66B | |
-12.75% | 7.04B | |
+2.81% | 5.39B | |
-1.37% | 4.45B | |
+4.44% | 4.32B | |
-48.78% | 3.31B | |
+9.29% | 2.6B | |
-14.74% | 2.01B | |
-14.72% | 1.65B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Myriad Genetics : Goldman Sachs Starts Myriad Genetics at Sell With $25 Price Target